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Abstract
Background: Experimental infection of mice with Theiler’s murine encephalomyelitis virus (TMEV) is used as an
animal model of human multiple sclerosis. TMEV persists in susceptible mouse strains and causes a biphasic disease
consisting of acute polioencephalomyelitis and chronic demyelinating leukomyelitis. In contrast, resistant mice
eliminate the virus within 2 to 4 weeks, which seems to be based on a strong antiviral innate immune response
including the activation of the type I interferon (IFN) pathway. Several interferon-stimulated genes (ISGs) such as
IFN-stimulated protein of 15 kDa (ISG15), protein kinase R (PKR), and 2′5′-oligoadenylate synthetase (OAS) function
as antiviral effectors and might contribute to virus elimination. Nevertheless, detailed investigations of the type I IFN
pathway during TMEV-induced demyelinating disease (TMEV-IDD) are lacking.
Methods: The present study evaluated microarray data of the spinal cord obtained from susceptible SJL/J mice
after TMEV infection focusing on IFN-related genes. Moreover, ISG gene and protein expression was determined in
mock- and TMEV-infected SJL/J mice and compared to its expression in resistant C57BL/6 mice using real- time
PCR, immunohistochemistry, and immunofluorescence.
Results: Interestingly, despite of increased ISG gene expression during TMEV-IDD, ISG protein expression was impaired
in SJL/J mice and mainly restricted to demyelinated lesions. In contrast, high ISG protein levels were found in spinal
cord gray and white matter of C57BL/6 compared to SJL/J mice in the acute and chronic phase of TMEV-IDD. In both
mouse strains, ISG15 was mainly found in astrocytes and endothelial cells, whereas PKR was predominantly expressed
by microglia/macrophages, oligodendrocytes, and neurons. Only few cells were immunopositive for OAS proteins.
Conclusions: High levels of antiviral ISG15 and PKR proteins in the spinal cord of C57BL/6 mice might block virus
replication and play an important role in the resistance to TMEV-IDD.
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Background
Theiler’s murine encephalomyelitis virus (TMEV) is a
single-stranded ribonucleic acid (RNA) (ssRNA) Cardio-
virus of the Picornaviridae family, whose large open
reading frame (ORF) encodes a 2300-amino acid poly-
protein that is cleaved into 12 mature proteins [1]. TO
strains (BeAn, DA) of TMEV induce a biphasic disease
in susceptible SJL/J mice characterized by acute mild
polioencephalomyelitis and chronic demyelinating leuko-
myelitis with virus persistence. In contrast, resistant
C57BL/6 mice eliminate the virus from the central ner-
vous system (CNS) within 2 to 4 weeks [2]. After intrace-
rebral inoculation, TMEV primarily infects hippocampal
and cortical neurons [1]. In addition, the virus spreads to
neurons within the ventral horns of the spinal cord most
likely along axons and via the cerebrospinal fluid [3, 4].
Approximately 2 weeks after inoculation at the peak of
the specific immune response, the virus disappears from
neurons but persists in white matter glial cells and macro-
phages [5]. Demyelination is initially induced by virus-
mediated axonal damage recruiting inflammatory cells to
sites of Wallerian-like degeneration [6]. The subsequent
release and presentation of myelin breakdown products
causes a CD4+ T cell response directed against different
myelin proteins such as proteolipid protein, epitope
PLP139-151, by molecular mimicry and epitope spreading
[7]. The susceptibility of mouse strains to TMEV-induced
demyelination disease (TMEV-IDD) is linked to the major
histocompatibility complex (MHC) class I H-2D gene [8].
Consequently, the level of TMEV-specific CD8+ cytotoxic
T cells is higher in resistant compared to susceptible mice
in acute lesions [9]. In addition, MHC class II-restricted
CD4+ T cells play an important role in the induction of a
delayed-type hypersensitivity (DTH) response initially
directed against specific TMEV capsid proteins [10].
Due to similar histological and pathogenetic features,
TMEV-infected susceptible mice are commonly used to
model the most important demyelinating disease in
humans multiple sclerosis (MS) [3, 11]. The therapy of
MS strongly relies on different immunomodulatory and
immunosuppressive drugs including beta interferon (IFN-
β), which blocks T cell activation, increases interleukin
(IL)-10 expression, and maintains blood-brain barrier in-
tegrity [12, 13]. Similar IFN-β-dependent mechanisms
seem to reduce the demyelination in chronic TMEV-IDD
[7]. Furthermore, antiviral actions of this type I interferon
(IFN) have to be blocked by the TMEV leader (L) protein,
a 76-amino acid protein cleaved from the N-terminal end
of viral polyprotein, to establish virus persistence [14].
The L protein impedes IFN-β gene transcription by inter-
fering with IFN regulatory factor 3 (IRF3) dimerization
and nucleocytoplasmic trafficking [2, 15, 16]. Interestingly,
IRF3 contributes not only to early control of TMEV repli-
cation but also to TMEV-induced hippocampal injury
[17]. In addition, IRF3 polymorphisms strongly affect the
murine innate immune response and ability of TMEV to
persist in the CNS of different mouse strains [18]. Conse-
quently, TMEV-induced demyelination might result from
an insufficient infection control by the innate immune
response particularly the interferon system in susceptible
mice.
Type I IFN signal transduction is initiated by their cell
surface receptors, IFN alpha and beta receptors (IFNAR)1
and 2, which are linked to janus kinase 1 (JAK1) and tyro-
sine kinase 2 (TYK2). These two tyrosine kinases activate
the IFN-stimulated gene factor 3 (ISGF3) consisting of the
signal transducer and activator of transcription (STAT) 1
and 2 and IRF9, which enter the nucleus and bind to IFN-
stimulated response elements (ISREs) of more than 300
IFN-stimulated genes (ISGs) [19, 20]. The death of IFNAR
knockout mice after TMEV infection supports the prom-
inent role of ISGs in virus control [21]. IFN-stimulated
protein of 15 kDa (ISG15), protein kinase R (PKR), 2′5′-
oligoadenylate synthetase (OAS), and myxovirus resist-
ance (Mx) represent classical IFN-dependent antiviral
effectors detected by gene targeting studies [19]. In con-
trast to other ISGs, the effector functions of these proteins
have been characterized in detail. In addition, studies
using specific knockout mice have confirmed their anti-
viral activity against numerous virus families including
Picornaviridae [22, 23]. Consequently, mouse strain-
specific differences in their expression pattern might crit-
ically influence their ability to eliminate TMEV from the
CNS. ISG15 encodes an ubiquitin-like protein, which con-
jugates to numerous protein substrates to modulate pleio-
tropic cellular responses [21, 24]. PKR is activated by viral
double-stranded RNA (dsRNA) resulting in phosphoryl-
ation of the eukaryotic initiation factor 2α (eIF2α) and
inhibition of global protein synthesis including viral pro-
tein synthesis [19, 25]. OAS proteins including OAS1,
OAS2, OAS3, and OASL (OAS-like) are expressed at low
levels in unstimulated cells as inactive monomers, which
can be activated by viral dsRNA to form tetramers [26].
These tetramers activate the latent ribonuclease L (RNase
L) resulting in the degradation of viral and host cell RNAs
[19, 26]. Mx proteins are members of the dynamin-like
large guanosine triphosphatase (GTPase) family, whose
expression is exclusively controlled by type I IFNs [27].
Mx proteins bind viral nucleocapsid-like structures or
other viral components to prevent the generation of new
virus particles [27]. However, Mx proteins are not func-
tional in most laboratory mouse strains [28, 29] but might
be biomarkers to predict the therapeutic efficacy of IFN-β
treatment in MS [30].
The role of these classical ISGs in the neuropathogenesis
of TMEV-IDD has already been investigated in previous
studies. PKR is important for the recognition of TMEV
RNA in the cytoplasm of astrocytes [31] and the ensuing
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expression of several pro-inflammatory cytokines such
as IL-1, IL-6, IL-12p40, and TNF-α as well as chemo-
kines including different monocyte chemoattractant
proteins [32, 33]. In addition, PKR is required for pro-
duction of type I IFNs in response to TMEV in part by
regulating IFN messenger RNA (mRNA) integrity [34].
The OAS/RNase L pathway has been described to be
inhibited by the direct interaction of the ankyrin
domain of RNase L with TMEV L* protein, a 156-
amino acid long protein encoded by an alternative
TMEV ORF [35]. Surprisingly, primary mouse neurons
that are exposed to type I IFNs remain highly suscep-
tible to TMEV infection, which results from their het-
erogeneous response to IFN treatment revealed by a
lack of Mx1 expression. In addition, they have a low
level of basal ISG expression compared to fibroblasts
[36]. These data underline the cell type-specific differ-
ences in their IFN response. However, all these studies
have been performed in cell culture and have not inves-
tigated the expression of these antiviral effectors at the
protein level. Moreover, ISG cell type-specific expres-
sion patterns in the spinal cord including white matter
lesions of TMEV-infected mice remain unknown so far.
Consequently, the aim of this study was to compare the
expression of these four important ISGs in TMEV-IDD
between SJL/J and C57BL/6 mice in order to substanti-
ate the hypothesis that intrinsic differences in the inter-
feron system between these mouse strains are related to
their susceptibility to TMEV-induced demyelination.
Methods
Animals and Virus infection
Twenty-four 5-week-old female SJL/J HanHsd mice and
11 C57BL/6 mice (Harlan Winkelmann, Borchen,
Germany) were kept in a microisolator cage system
(Tecniplast, Hohenpeißenberg, Germany) with standard
bedding material (ssniff Spezialdiäten GmbH, Soest,
Germany) under a 12:12 h light/dark cycle. Food (R/M-
H V1534; ssniff Spezialdiäten GmbH) and water were
available ad libitum. They were inoculated into the right
cerebral hemisphere with 1.63 × 106 plaque-forming
units (PFU) per mouse of the BeAn strain of TMEV in
20 μl Dulbecco’s modified Eagle medium (DMEM; PAA
Laboratories, Cölbe, Germany) with 2 % fetal calf serum
and 50 μg/kg gentamycin under general anesthesia using
medetomidine (0.5 mg/kg, Domitor; Pfizer, Karlsruhe,
Germany) and ketamine (100 mg/kg, Ketamin 10 %;
WDT eG, Garbsen, Germany). Twenty-four 5-week-old
female SJL/J HanHsd and 12 C57BL/6 mice were
mock-infected using 20 μl DMEM only. TMEV- and
mock-infected mice were sacrificed in groups of five to
six animals at 14, 42, 98, and 196 days post infection
(dpi), respectively. Euthanasia was performed with a
fivefold overdose of the described anesthetics. Segments
of the spinal cord of mice were removed immediately after
death and either formalin-fixed and paraffin-embedded or
snap-frozen in OCT embedding compound (Sakura Finetek
Europe, Zoeterwoude, Netherlands) using liquid nitrogen
[37]. Microarray analysis was performed on 23 TMEV- (5
mice at 98 dpi; 6 mice at 14, 42, and 196 dpi) and 24 mock-
infected SJL/J mice (6 mice at all time points). Spinal cord
tissue obtained from these 47 SJL/J mice was also studied
using immunohistochemistry at all four time points. ISG
immunoreactivity and transcript numbers of selected genes
were compared between SJL/J and C57BL/6 mice at 14 dpi
(6 mock- and 6 TMEV-infected mice, respectively) and
98 dpi (6 mock- and 5 TMEV-infected mice, respectively)
using immunohistochemistry and reverse transcription
quantitative polymerase chain reaction (RT-qPCR), re-
spectively. Moreover, immunofluorescence was per-
formed on one additional TMEV-infected SJL/J mouse
due to the lack of adequate tissue from the other SJL/J
mice. Animal experiments were authorized by local author-
ities (Niedersächsisches Landesamt für Verbraucherschutz-
und Lebensmittelsicherheit, Oldenburg, Germany, permis-
sion numbers: 509c-42502-02/589, 509.6-42502-04/860,
33-42502-05/963, 33-42502-04-07/1292).
Microarray analysis
For microarray analysis, RNA was isolated from snap-
frozen spinal cord specimens using the RNeasy Mini Kit
(Qiagen, Hilden, Germany), amplified and labeled employ-
ing the MessageAmp II Biotin Enhanced Kit (Ambion,
Austin, TX, USA), and hybridized to GeneChip mouse
genome 430 2.0 arrays (Affymetrix, Santa Clara, CA,
USA) as previously described [38, 39]. Background adjust-
ment and quantile normalization was performed using
RMAexpress [40]. MIAME compliant data sets are de-
posited in the ArrayExpress database (E-MEXP-1717;
http://www.ebi.ac.uk/arrayexpress). Bottom-up analysis
of manually selected candidate genes was done using
classical statistics as previously described [41–43].
Accordingly, 111 candidate genes comprising 10 pat-
tern recognition receptors (PRRs), 10 IFN regulatory
factors, 9 type I/II IFNs, 4 type I/II IFN receptors, 8
signal transducers, 60 IFN-dependent antiviral effec-
tors, and 10 MHC class I/II genes were manually
extracted from peer-reviewed published literature
(Additional file 1: Table S1) [19, 22, 23, 44, 45]. The
fold change was calculated as the ratio of the inverse-
transformed arithmetic means of the log2-transformed
expression values of TMEV-infected vs. mock-infected
mice. Downregulations are shown as negative recipro-
cal values [39, 46]. The normalized expression values of
these genes were evaluated for significant differences
between TMEV- and mock-infected mice employing in-
dependent pairwise Mann-Whitney U tests (Prism 6,
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GraphPad Software, La Jolla, CA, USA). Statistical sig-
nificance was designated as P ≤ 0.05.
Polymerase chain reaction
RT-qPCR was performed for IFN-α (using consensus
primers annealing with all IFN-α subtypes), IFN-β, IRF-7,
ISG15, PKR, and three housekeeping genes (GAPDH, β-
Actin, HPRT) using standard protocols, the Mx3005P
qPCR System (Agilent Technologies Deutschland GmbH,
Böblingen, Germany), and Brilliant III Ultra-Fast SYBR®
QPCR Master Mixes [47]. The following primers were
used: IFN-α forward ATGGCTAGRCTCTGTGCTTTCCT;
IFN-α reverse AGGGCTCTCCAGAYTTCTGCTCTG;
IFN-β forward TGAATGGAAAGATCAACCTCACCTA;
IFN-β reverse CTCTTCTGCATCTTCTCCGTCA; IRF7
forward CGAGTGCTGTTTGGAGACTG; IRF7 reverse
GGCCTTGAAGATCTGTGCAT; ISG15 forward AACTG
CAGCGAGCCTCTGA; ISG15 reverse CACCTTCTTCTT
AAGCGTGTCTACAG; PKR forward GTACAAGCGCTG
GCAGAACTCAAT; and PKR reverse AAGAGGCACCG
GGTTTTGTAT. Tenfold serial dilution standards ranging
from 108 to 102 copies/μL were used to quantify the results.
A normalization factor achieved from the housekeeping
genes was calculated to correct for experimental variations
[48]. Specificity of each reaction was controlled by melting
curve analysis. Similar to microarray analysis, fold changes
were calculated to compare the respective results.
Histology and immunohistochemistry
Two- to three-micrometer paraffin spinal cord sections of
SJL/J mice at 14, 42, 98, and 196 dpi and C57BL/6 mice at
14 and 98 dpi were routinely stained with hematoxylin
and eosin (HE) or used for immunohistochemistry as de-
scribed [47]. Briefly, dewaxed and rehydrated sections
were incubated in ethanol with 0.05 % hydrogen peroxide
for 30 min to block endogenous peroxidase. Antigen re-
trieval was performed for the detection of PKR (boiled in
10 mM citrate buffer, 15 min, pH 6.0) and ISG15 and
OAS1 (trypsin solution with CaCl2 × 2 H2O, 20 min, pH
7.8). Subsequently, sections were blocked with phosphate-
buffered saline (PBS) containing 20 % horse serum (Mx1/
2/3) or 20 % goat serum (PKR, ISG15, OAS1) for 30 min
at room temperature. Sections were incubated with an
affinity-purified goat polyclonal anti-Mx1/2/3 antibody
(sc-34130, Santa Cruz Biotechnology, Santa Cruz, CA,
USA; 1:100), a rabbit monoclonal anti-PKR antibody (ab-
32036, Abcam, Cambridge, MA, USA; 1:400), or rabbit
polyclonal antibodies directed against ISG15 (sc-50366,
Santa Cruz Biotechnology; 1:200) or OAS1 (sc-98424,
Santa Cruz Biotechnology,; 1:400). Negative control sec-
tions were incubated with goat serum (G9023, Sigma-
Aldrich, Taufkirchen, Germany; 1:5650) and rabbit serum
(R4505, Sigma-Aldrich) diluted at the same gamma globu-
lin concentration as the primary antibodies. Biotinylated
horse-anti-goat antiserum (BA-9500, Vector Laboratories,
Burlingame, CA, USA; 1:200) and goat-anti-rabbit anti-
serum (BA-1000, Vector Laboratories; 1:200) were used as
secondary antibodies, and immunolabeling was visualized
by the avidin-biotin-peroxidase complex (ABC) method
(PK-6100, Vector Laboratories) with 3,3-diaminobenzidine
(DAB) as substrate. Finally, sections were slightly counter-
stained with Mayer’s hematoxylin.
Photos of ISG15, PKR, and OAS1 immunohistochemi-
cally stained sections were generated by a digital micro-
scope (HS All-in-one Fluorescence Microscope BZ-9000
Generation II; HS All-in-one Fluorescence Microscope
BZ-II Analyzer, BIOREVO, KEYENCE Deutschland
GmbH, Neu-Isenburg, Germany) and evaluated using
analysis software (analySIS 3.1 software package; Soft
Imaging system, Münster, Germany). Light microscopy
was used to count Mx-positive cells. In addition, ISG
positive and negative cells present in the Virchow-Robin
space of meningeal and intraparenchymal blood vessels
were counted to calculate the percentage of ISG15-,
PKR-, OAS1-, and Mx-positive perivascular cells. Immu-
nohistochemical results are expressed as median with
minimum and maximum.
Immunofluorescence double-labeling
Immunofluorescence was used to identify cells express-
ing ISG15 and PKR as described [49, 50]. Briefly, after
citrate buffer heat-mediated antigen retrieval and incu-
bation with PBS containing 20 % horse serum or 20 %
goat serum to block non-specific binding, paraffin sec-
tions were co-incubated with antibodies directed against
ISG15 (sc-50366; 1:100) or PKR (ab-32036; 1:200) and
antibodies directed against GFAP (ab-3554, Abcam;
1:200), Olig2 (ab-85900, Abcam; 1:500), or CD107b
(MCA2293, AbD Serotec, Puchheim, Germany; 1:200)
overnight at 4 °C. Negative controls included sections
incubated with rabbit serum (R4505, Sigma-Aldrich;
1:3000/1:6000), goat serum (I9140, Sigma-Aldrich;
1:4500), sheep serum (1:5000), and rat serum (R9759,
Sigma-Aldrich; 1:16000), respectively. After washing,
sections were incubated Cy2- and Cy3-conjugated sec-
ondary antibodies (goat anti-rabbit, A-11034, Invitrogen;
1:200; goat anti-rat, 112-165-003; donkey anti-rabbit,
711-545-152; donkey anti-sheep, 713-765-147; donkey
anti-goat, 705-765-147, Jackson ImmunoResearch, Suf-
folk, UK; 1:200) in the dark for 1 h at room temperature.
Nuclei were counterstained with 0.01 % bisbenzimide
(H33258, Sigma-Aldrich), and sections were mounted in
Dako Fluorescence Mounting Medium (S3023, Dako
Cytomation GmbH, Hamburg, Germany).
Statistical analysis
RT-qPCR data and immunohistochemical data of SJL/J
and C57BL/6 mice were analyzed using Kruskal-Wallis
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and non-parametric Mann-Whitney U tests (IBM SPSS,
version 19.0, IBM Corporation, Armonk, NY, USA). Ratios
of the geometric means and 95 % confidence intervals
were calculated with independent T tests to compare ISG
protein expression between C57BL/6 and SJL/J mice (IBM
SPSS, version 19.0). Spearman’s rank correlation coeffi-
cients were calculated to analyze the correlation between
ISG protein and gene expression as well as TMEV RNA
copy numbers, inflammation, and demyelination in the
spinal cord of SJL/J mice (IBM SPSS, version 19.0).
Data concerning TMEV, inflammation (determined on
hematoxylin and eosin and immunohistochemically
stained sections), and demyelination (determined on
luxol fast blue stained sections) have been taken from
previous publications [39, 51]. Statistical significance
was designated as P ≤ 0.05.
Results
Microarray
Recently, Ulrich et al. (2010) performed a microarray
analysis of mock- and TMEV-infected SJL/J mice at 14,
42, 98, and 196 dpi and detected transcriptional changes
of 1001 genes in the spinal cord. In the present study,
the log2-transformed normalized data were independ-
ently re-evaluated focusing on critical genes of the type I
IFN pathway employing conventional statistical methods
as described [41, 43, 52]. Most genes were significantly
up-regulated by TMEV infection and peaked at 98 dpi
(Fig. 1; Table 1; Additional file 1: Table S1). Only a mild
increase in Toll-like receptor (Tlr)3 gene expression
(fold change <2) was found, whereas other receptors of
viral RNA including Pkr, melanoma differentiation-
associated gene (Mda5), Tlr7, and Tlr13 were moder-
ately up-regulated (fold change up to 5.77). Nfkb1, lrf3,
and Irf5 gene expression was barely influenced by
TMEV infection. In contrast, Irf1 and Irf7 were strongly
up-regulated (fold change up to 4.40 and 11.42, respect-
ively). Interestingly, no changes were found in type I IFN
gene expression, and Ifnar genes were only mildly
increased in the late phase of TMEV-IDD. However,
gene expression of several factors critically involved in
IFN signal transduction, especially of the ISGF3 compo-
nents IRF9, STAT1, and STAT2, was moderately to
strongly up-regulated (fold change up to 15.39). In
addition, gene expression of various IFN-dependent
antiviral effectors was strongly increased in TMEV-IDD
(fold change up to 31.22). Similarly, several MHC class I
and II genes were strongly induced by TMEV infection
(fold change up to 37.55).
RT-qPCR
RT-qPCR of selected genes was performed to validate
microarray results of SJL/J mice and to compare gene
expression of SJL/J and C57BL/6 mice (Additional file 2:
Figure S1). In general, there was a good correlation
between RT-qPCR and microarray data in SJL/J mice re-
vealing highly similar fold changes of IRF7, ISG15, and
PKR at both 14 and 98 dpi. Nevertheless, minor changes
in type I IFN mRNA transcription were detected in SJL/
J mice using RT-qPCR, which were not found in the
microarray analysis.
IFN-α and IFN-β transcript numbers were not signifi-
cantly changed at 14 dpi in SJL/J mice (fold changes:
IFN-α: 1.33, IFN-β: −1.07). At 98 dpi mRNA levels of
both type I IFNs were downregulated (fold changes:
IFN-α: −2.12, IFN-β: −2.78), but only IFN-β differed sig-
nificantly (IFN-α: P = 0.052, IFN-β: P = 0.030). IRF7,
ISG15, and PKR were significantly up-regulated at
14 dpi (fold changes: IRF7: 4.96 (P = 0.009), ISG15: 4.13
(P = 0.009), PKR: 1.64 (P = 0.026)) and 98 dpi (fold
changes: IRF7: 11.53 (P = 0.017), ISG15: 21.12 (P =
0.004), PKR: 3.19 (P = 0.004)) in SJL/J mice.
C57BL/6 mice showed a significant increase in mRNA
levels of IFN-β at 14 dpi (fold change 3.73, P = 0.041) and
of IFN-α at 98 dpi (fold change 2.49, P = 0.017). TMEV
infection did not significantly influence the transcript
numbers of IFN-β at 98 dpi (fold change 1.42, P = 0.247)
and of IFN-α at 14 dpi (fold change −1.01, P = 1.000).
Similar to IFN-β, ISG15 was up-regulated at 14 dpi (fold
change 2.11, P = 0.026) but not at 98 dpi (fold change
Fig. 1 Type I IFN signaling pathway and transcriptional changes of
selected ISGs in the spinal cord of TMEV- compared to mock-infected
SJL/J mice. Left side: Pattern recognition receptors (PKR, RIG-I-like
helicases, Toll-like receptors) recognize viral proteins and RNA,
which induce the activation of second messengers (IFN regulatory
factors, NF-κB). These signal transducers translocate into the
nucleus and induce the transcription of IFNα/β. Right side: These
type I IFNs bind to the type I IFN receptor (IFNAR) to initiate signal
transduction via the JAK-STAT pathway. This pathway activates
specific transcription factors (ISGF3), which translocate into the
nucleus, bind to IFN-stimulated response element (ISRE) of the
DNA, and induce the transcription of abundant ISGs including
ISG15, PKR, OAS, and Mx. Thermometer-like icons display significant fold
changes (P≤ 0.05) at four time points (1 = 14 dpi, 2 = 42 dpi, 3 = 98 dpi,
4 = 196 dpi). Legend: IFN interferon, ISG IFN-stimulated gene, ISG15 ISG of
15 kDa, ISGF3 ISG factor 3, JAK janus kinase, Mx myxovirus-resistance
gene, NF-κB nuclear factor of kappa light polypeptide gene enhancer in
B cells, OAS 2′, 5′-oligoadenylate-synthetase, PKR protein kinase R, RIG-I
retinoic acid-inducible gene, STAT signal transducer and activator of
transcription, TMEV Theiler’s murine encephalomyelitis virus
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1.59, P = 0.177) in C57BL/6 mice. Statistical analysis de-
tected a tendency of increased IRF7 mRNA levels at both
time points (fold changes: 14 dpi: 2.24, P = 0.093; 98 dpi:
2.02, P = 0.052). PKR transcript numbers were not signifi-
cantly influenced by TMEV infection in this mouse strain
(fold changes: 14 dpi: 1.26, 98 dpi: 1.06).
Significant differences between the two mouse strains at
the mRNA levels of the investigated genes were predomin-
antly found at 98 dpi. In mock-infected mice, there were
higher transcript numbers of IFN-α (P = 0.041) and IFN-β
(P = 0.009) and lower mRNA levels of ISG15 (P = 0.009) in
SJL/J compared to C57BL/6 mice at this time point. In
TMEV-infected mice, there were higher transcript num-
bers of IRF7 (P = 0.008), ISG15 (P = 0.008), and PKR (P =
0.008) and lower mRNA levels of IFN-α (P = 0.016) in SJL/
J compared to C57BL/6 mice at 98 dpi. At 14 dpi, a signifi-
cant difference between the two mouse strains was only
detected for IFN-β, which was higher in mock- (P = 0.002)
and TMEV-infected (P = 0.002) SJL/J compared to C57BL/
6 mice.
Immunohistochemistry
TMEV infection induces ISG protein expression in SJL/J mice
In general, immunohistochemical analysis detected an in-
crease in ISG15, PKR, and OAS1 protein expression in
white matter lesions (Figs. 2 and 3). ISG15-positive cells
particularly ependymal cells, endothelial cells, astrocytes,
and microglia/ microphages were found in the spinal cord
of mock- and TMEV-infected SJL/J mice at all of time
points. A mild ISG15 expression was also found in some
neurons (Fig. 3a, b, e). ISG15 protein levels were higher in
the white matter of TMEV- compared to mock-infected
mice at 14 dpi (P = 0.004) and 42 dpi (P = 0.002), whereas
protein expression was only changed at 42 dpi in the gray
matter (P = 0.015; Fig. 2a, b).
PKR proteins were present in microglia/macrophages,
oligodendrocytes, and neurons at all investigated time
Table 1 Transcriptional changes of the type I IFN signaling
pathway in TMEV- compared to mock-infected SJL/J mice
Gene symbol 14 dpi 42 dpi 98 dpi 196 dpi
Pattern recognition receptors
Eif2ak2 (Pkr) 1.69 3.04 3.73 2.18
Ifih1 (Mda5) 2.20 4.86 5.77 3.51
Tlr2 1.77 2.66 3.31 2.94
Tlr3 1.18 1.37 1.89 1.38
Tlr7 1.18 1.87 2.47 2.43
Tlr13 1.33 2.50 3.46 3.27
Interferon regulatory factors
Irf1 1.51 3.47 4.40 3.11
Irf3 1.07 1.06 1.09 1.18
Irf5 1.07 1.40 1.81 1.57
Irf7 2.66 10.12 11.42 4.46
Nfkb1 1.14 1.14 1.20 1.10
Type I interferons
Ifna1 1.04 −1.10 −1.06 −1.08
Ifnb1 1.02 1.07 −1.08 −1.11
Type I interferon receptors
Ifnar1 1.01 −1.02 1.14 1.15
Ifnar2 1.10 1.51 1.72 1.50
Signal transducers
Irf9 2.53 4.92 4.72 3.21
Jak1 1.01 1.02 −1.04 1.06
Socs1 1.01 1.31 1.48 1.14
Stat1 3.26 10.58 15.39 9.57
Stat2 1.39 2.49 3.30 2.03
Tyk2 1.15 1.12 1.32 1.19
Classical interferon stimulated genes
Isg15 3.23 11.58 15.71 6.59
Mx1 1.34 2.11 3.85 1.88
Mx2 1.24 1.61 1.76 1.31
Oas1a 2.71 7.92 11.07 6.73
Oas2 1.32 2.26 2.59 2.08
Oas3 1.01 1.59 1.75 1.23
Oasl1 1.61 2.81 3.65 1.99
Oasl2 6.70 25.78 29.16 12.93
Rnasel −1.16 1.37 1.54 1.29
Major histocompatibility (MHC) genes class I/II
H2-D1 (MHC-Ia) 5.58 8.03 9.78 9.42
H2-K1 (MHC-Ia) 5.42 7.45 9.70 8.56
H2-M3 (MHC-Ib) 1.62 2.80 3.48 3.25
H2-Q5 (MHC-Ib) 2.46 9.75 13.88 10.7
H2-Aa (MHC-IIa) 5.49 29.30 37.55 29.10
H2-Eb1 (MHC-IIa) 5.11 20.11 28.18 21.00
Table 1 Transcriptional changes of the type I IFN signaling
pathway in TMEV- compared to mock-infected SJL/J mice
(Continued)
H2-DMa (MHC-IIb) 1.31 2.93 4.23 3.22
H2-Oa (MHC-IIb) 1.25 2.78 4.39 2.79
Shown are fold changes at 14, 42, 98, and 196 dpi. Italic type indicates
statistically significant up-regulation (P ≤ 0.05)
Legend: Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 4, H2-Aa
H2 antigen A alpha, H2-D1 H2-D region locus 1, H2-DMa H2 antigen locus
DMa, H2-Eb1 H2 antigen E beta 1, H2-K1 H2-K region locus 1, H2-M3 H2-M
region locus 3, H2-Oa H2-O region alpha locus, H2-Q5 H2-Q region locus 5, Ifih
interferon induced with helicase C domain, Ifit interferon-induced protein with
tetratricopeptide repeats, Ifna interferon alpha, Ifnb interferon beta, Ifnar interferon
(alpha and beta) receptor, Irf interferon regulatory factor, Isg interferon-stimulated
protein, Jak Janus kinase, Mx Myxovirus (influenza virus) resistance, Nfkb
nuclear factor of kappa light polypeptide gene enhancer in B cells, Oas 2′-5′
oligoadenylate synthetase, Rnasel Ribonuclease L (2′, 5′-oligoisoadenylate
synthetase-dependent), Socs suppressor of cytokine signaling, Stat signal
transducer and activator of transcription, Tlr Toll-like receptor, Tyk
tyrosine kinase
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points in mock- and TMEV-infected mice (Fig. 3c, d). In
addition, positive gitter cells were found in the white matter
of TMEV-infected SJL/J mice at 98 and 196 dpi (Fig. 3f).
Similar to ISG15, PKR protein levels were increased by
TMEV infection, but a significant difference was only found
in the white matter at 196 dpi due to strong intralesional
expression (P = 0.002; Figs. 2d and 3e, f).
OAS1 was mainly expressed by neurons and microglia
in mock- and TMEV-infected mice (Fig. 3g, h). In gen-
eral, there was a low OAS1 protein expression at all
investigated time points (Fig. 2e, f ). Nevertheless, OAS1
protein levels were significantly higher in the white
matter of TMEV- compared to mock-infected mice at
42 dpi (P = 0.026) and 98 dpi (P = 0.004; Fig. 2f ). Corre-
sponding to low IFNα and IFNβ gene expression, Mx
proteins were only found in few glial cells at 14 and
98 dpi.
Higher ISG protein expression in C57BL/6 compared to SJL/J
mice
The ISG protein expression in the spinal cord was com-
pared between susceptible SJL/J and resistant C57BL/6
mice at an early time point (14 dpi) and at the peak of
inflammatory demyelination and ISG gene induction
Fig. 2 ISG15, PKR, and OAS1 protein expression in the spinal cord of mock- and TMEV-infected SJL/J at 14, 42, 98, and 196 dpi. ISG15 (a, b), PKR
(c, d), and OAS1 (e, f) protein expression in spinal cord gray (a, c, e) and white matter (b, d, f). Shown is the percentage of immunopositive area
using Box-and-Whisker plots and significant differences between groups based on Mann-Whitney U tests (*P ≤ 0.05; **P ≤ 0.01)
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(98 dpi). Similar to SJL/J mice, only few Mx-positive
cells were detected in mock- and TMEV-infected
C57BL/6 mice indicating comparable low type I IFN
levels in both mouse strains. In contrast, ISG15 protein
levels were significantly increased in TMEV- compared
to mock-infected C57BL/6 mice in the gray (P = 0.026)
and white matter (P = 0.009) at 14 dpi and in the gray
matter (P = 0.017) at 98 dpi (Additional file 3: Figure S2).
PKR protein levels were significantly up-regulated in
TMEV- compared to mock-infected C57BL/6 mice in
the gray (P = 0.030) and white matter (P = 0.004) only at
98 dpi. OAS1 protein expression was not influenced sig-
nificantly by TMEV infection in C57BL/6 mice.
However, significant higher ISG15, PKR, and OAS1
protein expression was detected in the spinal cord gray
matter of TMEV-infected C57BL/6 compared to SJL/J
mice at 14 dpi (P = 0.007, P = 0.016, P = 0.003) and
98 dpi (P = 0.032, P = 0.001, P = 0.025; Figs. 4 and 5).
Fig. 3 ISG15, PKR, and OAS1 protein expression in the spinal cord of mock- and TMEV-infected SJL/J mice. a Low expression of ISG15 proteins in
mock-infected mice at 42 dpi. b High expression in endothelial cells and astrocytes of TMEV-infected SJL/J mice at 42 dpi. c Few cells express
PKR proteins in mock-infected SJL/J mice at 196 dpi. d Many oligodendrocytes, microglia/macrophages, and neurons express PKR proteins in
TMEV-infected SJL/J mice at 196 dpi. e Few intralesional cells express ISG15 at 98 dpi. f High PKR expression in intralesional gitter cells and some
perivascular immune cells in TMEV-infected SJL/J mice at 98 dpi. g Very low expression of OAS1 proteins of mock-infected SJL/J mice at 98 dpi.
h Few neurons, microglia, and perivascular immune cells express OAS1 proteins in TMEV-infected SJL/J mice at 98 dpi. Immunohistochemistry
visualized by the avidin-biotin-peroxidase complex method with 3,3-diaminobenzidine as substrate and counterstaining with Mayer’s hematoxylin.
Bar 100 μm
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Significant higher ISG15, PKR, and OAS1 protein levels
in the spinal cord white matter of TMEV-infected
C57BL/6 compared to SJL/J mice were only found at
14 dpi (P = 0.029, P = 0.017, P = 0.004). Furthermore,
there was a significant higher ISG15 expression of
mock-infected C57BL/6 compared to SJL/J mice in
spinal cord gray (P = 0.005) and white matter (P < 0.001)
at 14 dpi (Fig. 4). PKR and OAS1 protein levels were
also significantly increased in mock-infected C57BL/6
mice in the gray matter at 14 dpi (P = 0.01) and in the
Fig. 4 Comparison of the ISG15, PKR, and OAS1 protein expression between mock- and TMEV-infected C57BL/6 and SJL/J mice at 14 and 98 dpi.
ISG15 (a, b), PKR (c, d), and OAS1 (e, f) protein expression in spinal cord gray (a, c, e) and white matter (b, d, f). Shown are the ratios of the geometric
means and 95 % confidence intervals of immunopositive area between C57BL/6 and SJL/J mice using Box-and-Whisker plots and significant differences
between groups based on independent T tests (*P≤ 0.05; **P≤ 0.01). Note higher protein levels in C57BL/6 compared to SJL/J mice (ratio >1)
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white matter at 98 dpi (P = 0.01), respectively. At 14 dpi,
the difference in OAS1 expression in spinal cord white
matter between the two mouse strains after mock-
infection did not reach statistical significance (P = 0.052).
A perivascular infiltration of lymphocytes, plasma
cells, and macrophages was only found in TMEV-
infected mice. Few perivascular cells (<10 %) expressed
OAS1 or Mx proteins in both mouse strains. ISG15 was
found in 13 % (median; 0–44 %; minimum-maximum)
of the perivascular cells without significant differences
between 14 and 98 dpi or between SJL/J and C57BL/6
mice. PKR positive perivascular cells were only detected
in one SJL/J (6 %) and one C57BL/6 mouse (25 %) at
14 dpi. In contrast, a significant higher percentage of
perivascular cells (P = 0.036) expressed PKR in C57BL/6
mice (48 %; 38–75 %) compared to SJL/J mice (29 %;
25–36 %) at 98 dpi. However, perivascular cells were
rare in C57BL/6 mice and found only in three animals.
Immunofluorescence
Double-staining with cellular markers revealed PKR
expression in Olig2-positive oligodendrocytes (Fig. 6d)
and MAC-3-positive microglia/macrophages (Fig. 6f ),
whereas astrocytes did not express PKR (Fig. 6b). In
contrast, ISG15 co-localized with GFAP confirming its
astrocytic expression (Fig. 6a). In addition, few oligoden-
drocytes (Fig. 6c) and microglia/macrophages (Fig. 6e)
expressed ISG15.
Correlation analysis
ISG gene and protein expression was correlated to several
parameters characterizing the progression of TMEV-IDD
in SJL/J using Spearman’s rank correlation coefficients in
order to quantify the relationship of ISGs with viral load,
inflammation, and demyelination. The gene expression of
ISG15, PKR, OAS1, and Mx strongly correlated with
TMEV RNA, inflammatory cells including CD3+ T cells,
CD45R+ B cells, and MAC3+ microglia/macrophages, and
demyelination (rs ≥ 0.6; P ≤ 0.05; Table 2). In addition,
low but significant correlations were found between the
protein expression of ISG15, PKR, and Mx and their re-
spective gene expression, TMEV RNA, and all investi-
gated inflammatory cells (rs ≥ 0.4; P ≤ 0.05; Table 3).
ISG15 (rs = 0.3) and PKR (rs = 0.4) protein expression
was also significantly correlated to the extent of demye-
lination in the spinal cord. OAS protein expression was
only significantly correlated to the overall number of
inflammatory cells (rs = 0.3) and the number of intrale-
sional MAC3+ microglia/macrophages (rs = 0.4).
Discussion
Impaired protein expression of interferon-stimulated
genes in SJL/J mice
The present study investigated the expression of genes
critically involved in the type I IFN pathway during
TMEV-IDD. PRRs recognize pathogen-associated mo-
lecular patterns (PAMPs) such as viral and bacterial
components and induce intrinsic cellular defenses.
Double-stranded RNA formed during TMEV replication
is typically identified by PKR, MDA5, and TLR3 [31, 53,
54]. PKR, MDA5, and TLR2 gene expression was moder-
ately increased in the present study, whereas TLR3
mRNA levels were hardly affected by TMEV infection.
Nevertheless, previous studies already demonstrated that
TMEV induces an up-regulation of TLR2 via TLR3 sig-
nal and subsequently an activation of nuclear factor of
kappa light polypeptide gene enhancer in B cells (NF-
κB) causing the expression of several pro-inflammatory
cytokines and chemokines including IL-1β, IL-6, CCL2
(MCP-1), and CCL5 (RANTES) [32, 33, 55, 56]. In con-
trast to IRF3 and IRF5, IRF7 was strongly up-regulated
in the present study. Interestingly, the IRF7 protein must
be continuously produced due to its short half-life [57].
In addition, IRF3 function can be blocked by the TMEV
L protein [2, 15, 16]. Consequently, several PRRs might
be induced by TMEV and implicated in the activation of
the innate and adaptive immune response via NF-κB
and IRF7. A high NF-κB expression was already
described in microglia/macrophages in demyelinating
TMEV lesions [55]. The activation of the type I IFN
pathway by TMEV was also demonstrated by increased
transcription of various ISGs including MHC class I and
II genes, especially in the late phase of TMEV-IDD.
Fig. 5 ISG15 and PKR protein expression in the spinal cord of mock-
and TMEV-infected C57BL/6 mice. a Few cells express ISG15 proteins
in TMEV-infected SJL/J mice at 98 dpi. b Many endothelial cells,
astrocytes, and neurons express ISG15 proteins in TMEV-infected C57BL/6
mice at 98 dpi. c Low expression of PKR proteins in TMEV-infected SJL/J
mice at 98 dpi. d High expression of PKR proteins in oligodendrocytes,
microglia/macrophages, and neurons of TMEV-infected C57BL/6 mice at
98 dpi. Immunohistochemistry visualized by the avidin-biotin-peroxidase
complex method with 3,3-diaminobenzidine as substrate and
counterstaining with Mayer’s hematoxylin. Bar 100 μm
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Correspondingly, high correlation coefficients were
found between ISG gene expression and TMEV RNA as
well as inflammation and demyelination.
However, type I IFN production was blocked in the
spinal cord of TMEV-infected SJL/J mice, and up-
regulation of ISG transcription might depend on
increased expression of ISGF3 or even IRF1, which can
directly induce ISG transcription and thereby exert anti-
viral functions in the absence of IFN [23]. The lack of
type I IFN might be related to the strong OASL1
expression found in the present study, which inhibits the
translation of the potent type I IFN inducer IRF7 [58].
In addition, the increase in ISG protein expression,
which only weakly correlated with its gene expression,
was mainly restricted to late white matter lesions. Low
ISG protein levels in the early phase of TMEV-IDD in
this susceptible mouse strain indicate an intrinsic and/or
virus-dependent impairment of these IFN-dependent
Fig. 6 ISG15 and PKR protein expression of astrocytes, oligodendrocytes, and microglia/macrophages in spinal cord white matter lesions at
98 dpi. ISG15 (green) is expressed by astrocytes (red, a), oligodendrocytes (red, c), and microglia/macrophages (red, e) demonstrated by an orange-yellow
mixed color (arrows). No co-localization of PKR (green, arrowheads) with GFAP (red, arrows) indicates no/low PKR expression in astrocytes (red, b), whereas
co-localization of PKR (green) with Olig2 (red, d) and MAC-3 (red, f) demonstrates PKR expression in oligodendrocytes and microglia (arrows).
Immunofluorescence double-staining for ISG15 and PKR with GFAP, Olig2, and MAC-3. Nuclei are stained with bisbenzimide. Bar 25 μm
Table 2 Spearman’s rank correlation coefficients between ISG15, PKR, OAS1, Mx1, and Mx2 gene expression with TMEV RNA,
inflammation, T cells, B cells, microglia/macrophages, and demyelination in the spinal cord of SJL/J mice
ISG mRNA TMEV RNA Inflammation (HE) T cells (CD3) B cells (CD45R) Microglia/ Macrophage (MAC3) Demyelination (LFB)
ISG15 0.809 0.832 0.793 0.714 0.796 0.660
PKR 0.831 0.797 0.798 0.709 0.788 0.638
OAS1 0.816 0.839 0.775 0.736 0.808 0.688
Mx1 0.708 0.762 0.645 0.681 0.775 0.585
Mx2 0.755 0.746 0.663 0.763 0.748 0.632
Significant correlations are marked in italics (P ≤ 0.05)
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antiviral effectors. This most likely favors virus spread
within the CNS and infection of white matter glial cells.
Furthermore, an impaired immune response gives the
virus enough time to cause initial damage to myelin
sheaths resulting in the release of myelin breakdown
products. As soon as a DTH response directed against
myelin sheath components has established, pro-
inflammatory effects of high ISG expression within white
matter lesions can even promote demyelination by
enhancing antigen presentation and activating additional
autoreactive immune cells. Consequently, a strong anti-
viral immune response in the early phase of TMEV-IDD
is critical to prevent virus persistence and initiation of
the demyelination process, a time point which might
even define an antiviral vs. pro-inflammatory outcome
of ISG actions.
Higher ISG protein levels in C57BL/6 compared to SJL/J
mice
In contrast to SJL/J mice, TMEV infection induced type I
IFN transcription in C57BL/6 mice. Nevertheless, absolute
IFN-β mRNA levels were higher in SJL/J compared to
C57BL/6 mice at 14 dpi. RT-qPCR also revealed higher
IRF7, ISG15, and PKR transcript number in TMEV-
infected SJL/J at 98 dpi. However, immunohistochemistry
demonstrated similar or higher protein levels of ISG15,
PKR, and OAS1 in the spinal cord white and gray matter
of resistant C57BL/6 mice. Moreover, ISG15 and PKR
protein levels were further increased by TMEV infection.
ISG15 has been reported to inhibit IRF3 degradation [59]
and enhance NF-κB signaling via suppression of protein
phosphatase 1B (PPM1B) [60]. Downstream targets of the
transcription factors IRF3 and NF-κB including IFN-β and
pro-inflammatory cytokines play an important role in the
innate immune response to TMEV infection. Interestingly,
the main ISG15 expressing cells were astrocytes, endothe-
lial cells, and ependymal cells, which line the ventricular
system and the central canal of the spinal cord. This
expression pattern puts ISG15 in the first line of defense
to restrict virus spread in the CNS via the liquorogenic
route [3]. PKR is required for type I IFN production in re-
sponse to TMEV by acting as cytoplasmic RNA sensor
and stabilizing IFN mRNA integrity [32]. Moreover, PKR
is itself up-regulated by type I IFNs and exerts direct anti-
viral effects [25, 61]. Similarly, OAS1 protein might act as
antiviral effector in TMEV-infected C57BL/6 mice restrain-
ing virus spread in the spinal cord before demyelination
starts. Nevertheless, due to the inhibition of the OAS/
RNase L pathway by the TMEV L* protein [35], the anti-
viral activity of RNase L might be similar in TMEV-infected
SJL/J and C57BL/6 mice despite different OAS1 protein
levels.
Conclusions
In conclusion, the type I IFN pathway is activated in
TMEV-infected mice inducing the transcription of various
ISGs. The translation of these genes seems to be impaired
in susceptible SJL/J mice limiting their antiviral function.
In contrast, a high constitutive expression of ISG15 and
PKR proteins in the spinal cord white and gray matter,
which was further increased by TMEV infection, might
block the spread of TMEV in C57BL/6 mice and prevent
demyelinating disease based on virus persistence.
Additional files
Additional file 1: Table S1. Transcriptional changes of the type I and II
IFN signaling pathway in TMEV- compared to mock-infected SJL/J mice.
Shown are fold changes at 14, 42, 98, and 196 dpi including P values
based on Mann-Whitney U tests. Bold type indicates statistically significant
up-regulation (P < 0.05). (DOC 233 kb)
Additional file 2: Figure S1. IFN-α, IFN-β, IRF7, ISG15, and PKR mRNA
levels in the spinal cord of mock- and TMEV-infected SJL/J and C57BL/6
mice at 14 and 98 dpi. Shown are IFN-α (A), IFN-β (B), IRF7 (C), ISG15 (D),
and PKR (E) transcript numbers using Box-and-Whisker plots and significant
differences between groups based on Mann-Whitney U tests (*P≤ 0.05;
**P≤ 0.01). (TIF 10550 kb)
Additional file 3: Figure S2. ISG15, PKR, and OAS1 protein expression
in the spinal cord of mock- and TMEV-infected C57BL/6 at 14 and 98 dpi.
ISG15 (A–B), PKR (C–D), and OAS1 (E–F) protein expression in spinal cord
gray (A, C, E) and white matter (B, D, F). Shown is the percentage of
immunopositive area using Box-and-Whisker plots and significant differences
between groups based on Mann-Whitney U tests (*P≤ 0.05; **P≤ 0.01).
(TIF 3543 kb)
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Table 3 Spearman’s rank correlation coefficients between ISG15, PKR, OAS1, Mx1, and Mx2 protein levels with their gene expression
as well as TMEV RNA, inflammation, T cells, B cells, microglia/macrophages, and demyelination in the spinal cord of SJL/J mice
ISG protein ISG mRNA TMEV RNA Inflammation (HE) T cells (CD3) B cells (CD45R) Microglia/ Macrophage (MAC3) Demyelination (LFB)
ISG15 0.499 0.528 0.484 0.445 0.363 0.580 0.316
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Significant correlations are marked in italics (P ≤ 0.05)
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